Abstract

Insufficient evaluation of adverse events is not a proof of safety. Reply to LG Hemkens, U Grouven, R Bender, et al. [letter

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Insulin use and cancer risk in patients with type 2 diabetes: A systematic review and meta-analysis of observational studies
I.N Colmers ... J.A Johnson
Diabetes & Metabolism | VOL. 38
I.N Colmers, et. al.I.N Colmers ... J.A Johnson
15 Nov 2012
Abstract P4-13-07: Meta-analysis of epidemiological studies of Insulin Glargine and Breast Cancer Risk
A Koechlin ... M Bota
Cancer Research | VOL. 72
A Koechlin, et. al.A Koechlin ... M Bota
15 Dec 2012
A comparison of costs among patients with type 2 diabetes mellitus who initiated therapy with exenatide or insulin glargine
Derek Misurski ... Rosalind Fabunmi
Applied Health Economics and Health Policy | VOL. 7
Derek Misurski, et. al.Derek Misurski ... Rosalind Fabunmi
01 Dec 2009
Efficacy and Risk of Hypoglycemia With Use of Insulin Glargine or Comparators in Patients With Cardiovascular Risk Factors
Lawrence Blonde ... Mary Ann Banerji
Postgraduate Medicine | VOL. 126
Lawrence Blonde, et. al.Lawrence Blonde ... Mary Ann Banerji
01 May 2014
View more papers

More From: Diabetologia

Paper Title
Journal
Date
Author
Identification and validation of gestational diabetes subgroups by data-driven cluster analysis.
Benedetta Salvatori ... Christian S Göbl
Diabetologia | VOL. -
Benedetta Salvatori, et. al.Benedetta Salvatori ... Christian S Göbl
27 May 2024
Up Front.
-
Diabetologia | VOL. -
--
27 May 2024
Risk factors and prediction of hypoglycaemia using the Hypo-RESOLVE cohort: a secondary analysis of pooled data from insulin clinical trials.
Joseph Mellor ... Helen M Colhoun
Diabetologia | VOL. -
Joseph Mellor, et. al.Joseph Mellor ... Helen M Colhoun
25 May 2024
The association of chronic complications with time in tight range and time in range in people with type 1 diabetes: a retrospective cross-sectional real-world study.
Jolien De Meulemeester ... Pieter Gillard
Diabetologia | VOL. -
Jolien De Meulemeester, et. al.Jolien De Meulemeester ... Pieter Gillard
24 May 2024
View more papers